China National Medicines Corporation Ltd. (SHA:600511)

China flag China · Delayed Price · Currency is CNY
30.00
+0.42 (1.42%)
Mar 6, 2026, 3:00 PM CST
1.28%
Market Cap 22.64B
Revenue (ttm) 51.95B
Net Income (ttm) 2.01B
Shares Out 754.50M
EPS (ttm) 2.67
PE Ratio 11.25
Forward PE 10.70
Dividend 0.80 (2.67%)
Ex-Dividend Date Jun 18, 2025
Volume 7,379,926
Average Volume 5,680,513
Open 29.50
Previous Close 29.58
Day's Range 29.44 - 30.06
52-Week Range 27.57 - 31.55
Beta 0.31
RSI 64.79
Earnings Date Mar 20, 2026

About SHA:600511

China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental academic services, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. op... [Read more]

Sector Healthcare
Founded 1999
Employees 3,104
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600511
Full Company Profile

Financial Performance

In 2024, SHA:600511's revenue was 50.60 billion, an increase of 1.81% compared to the previous year's 49.70 billion. Earnings were 2.00 billion, a decrease of -6.80%.

Financial Statements

News

There is no news available yet.